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INTRODUCTION 
2 
There have been many pharmacotherapeutic agents employed to achieve 
successful pulpotomies in primary teeth. The use of formocresol, calcium 
hydroxide (CaOH), glutaraldehyde, ferric sulfate, and zinc oxide-eugenol (ZOE) 
have been used as pulpotomy agents, but with variable success. The use of 
formocresol as a pulpal medicament was first introduced by Sweet1 in 1954 and 
has since been a popular agent of choice for use in the pulpotomy procedure, 
mainly because of ease in use and excellent clinical success. Surveys suggest that 
the formocresol pulpotomy in primary teeth is considered the treatment of choice 
in a majority of pediatric dentistry departments in North America.2 Even though 
this pharmacologic agent is commonly used and produces very successful 
results, there are several animal studies that show that formocresol, or one of its 
metabolites, is apparent outside the tooth locally or systemically.3-8 The concern 
over the systemic distribution of formocresol and its potential for toxicity, 
allergenicity, carcinogenicity, and mutagenicity have led investigators to search 
for a safe and effective agent to be used in the pulpotomy procedure. The 
current trend is in reducing the toxicity of the standard drugs or finding new 
biocompatible agents.9 Any pulpotomy medicament or treatment used today to 
supplant the formocresol technique must be supported by well-documented 
evidence that the technique is effective, nonmutagenic, nonimmunogenic, and 
nondiffusable from the pulp canals.10 
The development of a safe and effective nonpharmacologic technique, 
such as electrosurgery, would eliminate the need for the use of chemotherapeutic 
agents to achieve hemostasis during pulpotomy procedures. This research is 
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designed to compare the clinical and radiographic results of the electrosurgical 
and formocresol pulpotomy technique used on human primary molar teeth 
requiring pulp therapy after carious involvement. The hypothesis of this study is 
that clinical and radiographic success rates for the electrosurgical pulpotomy 
technique will be comparable to the clinical and radiographic success rates for 
the formocresol pulpotomy technique in human primary molars. With the use of 
a nonpharmacologic technique, concerns regarding the toxicity of 
chemotherapeutic agents used in the pulpotomy procedure can be eliminated. 
4 
REVIEW OF LITERATURE 
5 
The primary indication for a pulpotomy in primary teeth is infected 
coronal pulp tissue with healthy, vital radicular tissue, or affected but still vital 
tissue with no irreversible infection, by clinical and radiographic criteria. The 
1995-1996 American Academy of Pediatric Dentistry Guidelines for Pulp 
Therapy for Primary and Young Permanent Teeth describe the pulpotomy 
procedure in primary teeth as amputation of the coronal portion of the affected 
or infected dental pulp, to preserve the vitality and function of all or part of the 
remaining radicular portion of the pulp.11 Successful therapy requires that: 
1. the vitality of the majority of the radicular pulp is maintained; 
2. there are no prolonged adverse clinical signs or symptoms such as 
prolonged sensitivity, pain, or swelling; 
3. no radiographic evidence is present of internal resorption or abnormal 
canal calcification; 
4. no breakdown of periradicular supporting tissues has occurred and; 
5. no harm has been done to succedaneous teeth. 
Many pharmacotherapeutic agents have been employed to meet the above 
criteria when performing pulpotomies on primary teeth. Ranly,12 in 1982, stated 
that the cells of the primary pulp are designed to provide resorption and are very 
easily stimulated toward that end. He said an ideal agent would fix the coronal 
pulp sufficiently to sterilize, detoxify, suppress metabolic activity, and inhibit 
autolysis without a continual devitalization of the radicular tissue. As 
mentioned earlier, formocresol has been a popular agent of choice for use in the 
pulpotomy procedure. Other medicaments, such as CaOH, glutaraldehyde, 
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ferric sulfate, and freeze-dried bone have been suggested as possible 
replacements for formocresol. Success rates have been variable depending on 
the agent used and the particular study; however, it is clear that additional 
research is required into the use of these and other pharmacotherapeutic agents. 
The formocresol pulpotomy was first introduced in 1954 by Sweet1 and 
since has been revised.13'14 Formocresol is thought to reduce post-endodontic 
pain, mummify residual pulpal tissue, and reduce the inflammatory reaction. 
Formocresol has been advocated in endodontic therapy to achieve canal 
sterilization, but studies have shown formocresol' s action to be bacteriostatic.15 
Buckley's formula is the most accepted and widely used formocresol in dentistry 
today. The formula contains 19-percent formaldehyde, 35-percent cresol and 15-
1 . d 16 percent g ycerme, an water. 
Formaldehyde, the simplest form of the aldehydes, is a gas produced by 
the incomplete combustion of methanol. In aqueous solution, formaldehyde is 
known as formalin. When formalin is diluted, the paraformaldehyde is 
redissolved into aqueous formaldehyde. The action of formaldehyde on the pulp 
is to prevent autolysis of tissue. This is accomplished by the chemical bonding of 
formaldehyde with proteins of the microorganisms found in the pulp. Glycerin 
is added to lessen the polymerization of the paraformaldehyde, which causes a 
"clouding" and results in less formaldehyde being present.16 Cresol is a caustic 
and pungent organic compound that destroys cellular integrity and homogenizes 
the pulp. Cresol is not a fixative, but a strong disinfectant.17 
Despite its long-term use and tremendous success rate, there has been 
much scrutiny over the use of formocresol in dentistry. Concerns regarding the 
systemic distribution of this agent and its potential for toxicity, allergenicity, 
carcinogenicity, and mutagenicity have led to additional research investigations 
into possible options. Formocresol has been shown to produce irreversible 
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damage to connective tissue and delays recovery of normal biological activities 
of affected connective tissue cells in rats. Formaldehyde alone alters the blood 
flow in the pulp and induces thrombus formation causing ischemia. The 
ischemia causes autolytic changes and coagulation necrosis resulting in 
deprivation of normal nutrients and respiration to the tissues.16 Local effects 
have been implied when treating primary molars with formocresol, including 
defects in the enamel on the succedaneous tooth.1,18 
The systemic distribution of formocresol in animals has been 
demonstrated in the vascular system after formocresol' s use as a pulpotomy 
medicament. Also, formocresol has been found in the dentin, the pulp, and the 
urine.7 According to a literature review by Judd and Kenny, the breakdown of 
formocresol occurs mainly in the liver, but breakdown products have been noted 
in erythrocytes, the kidneys, the lungs, and the brain.19 In another review by 
Sipes and Binkley, findings show that formocresol cannot be confined to the 
dental pulp. The degree and extent of changes are dependent on the dose of 
~ormocresol used, because it is transported via the blood vessels. Therefore, it 
has been recommended that the dose of formocresol be reduced to one-fifth 
because the incidence of deleterious effects will be decreased, without 
diminishing the effectiveness in tissue fixation. 15 
Formaldehyde is a toxic molecule that elicits a cellular and humoral 
immune response.15 Toxic levels of formocresol have been shown to produce 
cardiovascular alterations and histologic changes in the heart, kidney, liver, and 
lung tissues of dogs.6 It is an intermediate metabolite in the mammalian 
biosynthesis of purine, thymine, histidine, and serine and is metabolized to 
formic acid, carbon dioxide, and other metabolites involved in amino acid 
formation.19 Therefore, the most susceptible organ for potential injury is the 
kidney.19 The cells and tissues of the young are generally more prone to 
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chemical effects than those of adults due to developmental stage. Concerns 
regarding allergenicity with formocresol have been noted. Patients being treated 
for or diagnosed with eczema are routinely screened for formocresol 
sensitization.19 In 1946, formaldehyde, a component of formocresol, was found 
to possess mutagenic properties.15 The Federal Panel on Formaldehyde 15 stated 
that this compound should be regarded as possessing a carcinogenic risk to 
humans. The interaction of formocresol with genetic material of cells has shown 
the potential for carcinogenic and mutagenic changes.19 
Formaldehyde is thought to be an initiator and a promoter, in that it has 
the capacity to damage DNA. This can lead to neoplastic transformation and 
cause cellular toxicity and regenerative proliferation with a promotional effect on 
carcinogenesis.19 Formaldehyde has produced mutations in human 
lymphoblastoid cells20 and causes an increased rate of cell turnover in respiratory 
21 22 
mucosa. Swenberg, et al. demonstrated that the vapor from formaldehyde 
will induce nasal squamous cell tumors in rats, and that long-term contact with 
formocresol is capable of transforming the epithelium into precancerous and 
cancerous states. The evidence that formocresol has the potential for human 
carcinogenic risk has been proven with animal bioassay models.19 Therefore, 
mutagencity and carcinogenicity must be considered when using fonnocresol, 
even though the risk is incalculable. The relative toxicity is probably minor, if 
one considers the small quantity used in the pulpotomy technique. 
Several studies have evaluated the clinical, radiographic, and histologic 
success of the formocresol pulpotomy technique. In 1965, Berge~, et al.16 
evaluated the reaction of fonnocresol and ZOE histologically, radiographically, 
and clinically when used for treatment of cariously exposed pulp tissue of 
primary teeth. Pulpotomies were performed on 52 primary molars of 40 
children. The teeth were treated with a five-minute forrnocresol application and 
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then with either ZOE or a ZOE paste with formocresol was placed over the 
pulpal orifice. Then the teeth were restored with an alloy. Selection criteria 
consisted of primary teeth with a carious pulp exposure without clinical 
evidence of degeneration, no more than one-fourth of root resorption present, 
and vitality as defined by hemorrhaging.16 Histologically, three weeks after the 
formocresol treatment, the tissue appeared compressed and well-defined in the 
coronal aspect. Complete absence of cellular detail was noted in the apical third. 
By the seventh week there was an ingrowth of granulation tissue through the 
foramen that was replacing the necrotic tissue in the pulp canals. At 38 weeks 
the granulation tissue appeared to progress coronally up to the amputation site. 
Osteodentin was found lining the canal walls. The teeth treated with ZOE 
presented with active inflammation and internal resorption. The success rate 
histologically for formocresol was 82 percent. The radiographic success rates for 
formocresol and ZOE were 97 percent and 58 percent, respectively. This study 
shows that formocresol can be used as a pulpotomy agent with anticipation of 
· good results. It is apparent in this study and others that ZOE produces 
persistent inflammation when in contact with pulp tissue and should not be used 
t f 1 t . 16,23 as an agen or pu po onues. 
Rolling, et al. 24 evaluated the state of the pulp of 19 primary molars that 
had been treated with formocresol and been determined to be successful 
clinically and radiographically for a period of three to 24 months. The aim was 
to establish a relation between the pulpal condition on a short-term and a 
long-term basis. The criteria used to identify a tooth needing a pulpotomy was 
the exposure of a vital pulp after excavation of caries, no periradicular 
pathology, and the ability to restore. The results indicated that pulpal changes 
occurred in all teeth ranging from acute to chronic inflammation, osteodentin 
formation along canal walls, and necrosis. Rolling considers the formocresol 
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method only a means to keep primary teeth functioning for a limited period of 
time. 
25 Fenton and Rapp evaluated the effects formocresol had on the 
vasculature of primary pulp tissue in the Macaca rhesus monkey. The researchers 
performed the conventional five-minute formocresol pulpotomy on 12 teeth and 
extracted them 84 days postoperatively. The results indicated perfused arterioles 
and venules in the pulp canal with poor differentiation at the apical portion due 
to close proximity of the vessels. The venules were located centrally and 
appeared larger than the arterioles with good drainage. The arterioles were 
located along the lateral walls of the pulp near the periphery, and a joining of the 
arterioles and venules by capillary plexuses was noted. It was concluded that the 
vascularity of the pulp tissue was not altered by the use of formocresol. 
Another chemotherapeutic agent that has been investigated is CaOH. It is 
considered a safe drug in comparison with formocresol. The rationale for using 
CaOH for a pulp dressing in the primary dentition is that it is more biologically 
s~und and promotes reparative dentin formation and physiologically sound 
roots.
17 It was the first agent to demonstrate the capacity to induce regeneration 
of bone.9 A concern about CaOH is that the high pH wounds the pulp and 
permits the reparative process to begin, but the stimulus evoked is balanced 
between one of healing and one of resorption.9 Magnusson, et al.26 investigated 
the clinical and histologic effects of CaOH paste as a wound dressing. The 
results showed that the agent caused a destructive process, which was usually 
internal root resorption. Doyle13 reported that the histologic success rate when 
comparing calcium hydroxide to formocresol was 50 percent and 92 percent, 
respectively. The hard setting preparations of calcium hydroxide have been 
recommended, because it releases fewer hydroxyl ions and is gentler to the pulp. 
Heileg,27 in 1984, used Life, a hard setting CaOH, as a pulpotomy agent. The 
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results were encouraging, but the study lacked sufficient numbers and was too 
short-term to be considered legitimate in comparing the efficacy of the 
hard-setting preparation to the conventional CaOH. 
In 1978, Schroder28 performed pulpotomies on primary teeth using CaOH. 
The success rate was between 38 and 59 percent after two years. The most 
frequent complication seen in this study was internal resorption below the 
amputation site. This commonly occurred within the first six months. Schroder 
attributes the low success rate to leaving a blood clot on the wound surface and 
recommends taking steps to improve the technique, so that CaOH can be applied 
to a wound surface free of blood clots. Despite the desirable properties of CaOH, 
it often results in internal root resorption, and use cannot be recommended 
pulpotomies in the primary dentition. However, CaOH continues to be the 
medicament of choice in the permanent dentition.17 
Another pharmacological agent used for pulpotomies is glutaraldehyde. 
It is a fixative used for electron microscopy, cytochemistry, and sterilization of 
· smgical equipment and instruments. 29 Gluteraldehyde has also been used in 
human aortic valve implants due to a perceived ability to reduce antigenicity. 
30 Gravenrnade suggested the use of glutaraldehyde as a pulpotomy agent 
because of its bactericidal effects and because its fixative properties are less 
destructive than those of formocresol. Glutaraldehyde has the ability to establish 
intramolecular I intermolecular protein bonds of a macromolecular size, and this 
cross-linking of protein chains should prevent a recurrence of inflammation. 
Kopel, et al.31 examined the reaction of the radicular pulp to 
glutaraldehyde in 30 children with carious primary molars indicated for a 
pulpotomy. The teeth were treated with 2-percent glutaraldehyde mimicking the 
five-minute formocresol technique and then evaluated at five minutes, one week, 
and at one, three, six, and 12 months. The histologic results showed the 
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replacement of the fixed tissue at the amputation site with connective tissue and 
the formation of osteodentin along the canal walls. The remaining pulp tissue 
was judged to be vital. The results would suggest that glutaraldehyde is an 
acceptable medicament for maintaining vitality in pulpally treated teeth. 
van Velzen and van den Hooff2 concluded in their 1977 study that the 
aging process of the pulp tissue occurring from the use of glutaraldehyde is 
probable, because the fixed tissue is undergoing phagocytosis. This results in 
collagenous fibers being formed at the amputation site, and the narrowing of the 
canals is due to the formation of reparative dentin. Dankert, et al. 33 found only 
minimal diffusion of glutaraldehyde through the apices, and these findings are 
related to the strong ability of glutaraldehyde to establish intramolecular protein 
bonds, which reduce its solubility. Even though glutaraldehyde has proved to be 
successful clinically, the concern for systemic distribution, toxicity, allergenicity, 
carcinogenicity, and mutagenicity must be investigated before the routine use of 
gluteraldehyde as a pharmacologic agent can be recommended. 
Ferric sulfate, another chemotherapeutic agent, has also been reported in 
the literature as a possible medicament for treating pulpally involved teeth in the 
primary dentition. It is used in gingival retraction cord and endodontic surgery 
because of its hemostatic properties. When ferric sulfate contacts blood, an ion-
protein complex forms and seals the cut blood vessels mechanically.34 Landau 
and Johnson35 reported the use of ferric sulfate in pulpotomized monkey teeth to 
help control hemmorhage before the application of the pulpotomy agent. It was 
shown to provide adequate hemostasis with no fixation of tissue. 
Fei, et al.34 compared the clinical and radiographic success of ferric sulfate 
and formocresol as a pulpotomy medicament. Pulpotomies were performed on 
83 primary molars. The teeth were divided into two groups, one using 15.5 
percent ferric sulfate and the other using the conventional forrnocresol solution. 
13 
The specimens were evaluated at three, six, and 12-month intervals. The results 
showed that ferric sulfate was 96-percent successful, compared with the 
77-percent success rate of formocresol. The initial use of ferric sulfate has proved 
to be successful clinically, but there is a need for further studies that include 
histological evaluation before ferric sulfate can be considered an acceptable 
pulpotomy agent. 
Finally, another pharmacologic agent that has been investigated is 
freeze-dried bone. It is used as a grafting material for osseous defects in 
periodontal surgery and has been implemented in the fields of orthopedics and 
oral maxillofacial surgery.36 McClean and Urise7 observed that the proteins in 
the matrix of bone and dentin contain precursors for inducing bone formation. 
This has also been proved through clinical and histological studies. The 
induction of bone formation is from the interaction of freeze-dried bone with the 
mesodermal cells during the resorptive phase. Because freeze-dried bone acts as 
a stimulator for osteogenesis and cementogenesis, it would be reasonable to 
· assume that freeze-dried bone would react favorable as a pulpotomy agent 
(because the pulp and dentin are comprised of mesodermal tissues).36'38,39 
Fadavi, et al.36 studied the effect of freeze-dried bone on amputated pulps 
on 15 primary teeth of monkeys. The histologic results showed a formation of 
reparative dentin along the canal walls, which suggests an effort by the pulp to 
heal the area of insult. This also would suggest that freeze-dried bone could be a 
viable pulp amputation dressing without the dissemination and toxic 
ramifications of formocresol. The results appear favorable; however, further 
studies are needed to determine the long-term effects that freeze-dried bone has 
on the pulp; this study terminated after 12 weeks. 
Besides chemotherapeutic agents, the use of nonpharmacologic techniques 
have been researched, i.e., electrosurgery and laser therapy. The use of lasers is 
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being implemented into many areas in the field of dentistry. Adrian, et al. 40 
reported the effects of a ruby laser on the dental pulp, and Shoji41 reported the 
use of a C02 laser on the pulp tissue. The C02 laser has several advantages over 
other lasers. It makes a bloodless tissue incision; it has no mechanical contact 
with the tissue, provides hemostasis, and reduces bacterial contamination. 
Pulpotomies were performed on 10 mongrel dogs by using a focused and a 
unfocused laser beam at different output levels and intervals. The teeth were 
evaluated immediately after the procedure. Using the unfocused beam with a 
high output and low-interval period produced adequate charring of the dentin 
and pulp tissue. The preliminary results of laser therapy are promising, but 
further studies are needed to determine the effect that lasers have on the pulp 
and the clinical efficacy of this agent. 
The use of electrosurgery as a nonpharmacologic pulpotomy technique 
has been well-documented and proven to have merit. It is much quicker than the 
formocresol technique; it is self-limiting; the pulpal penetration is only a few cell 
· layers deep; ES provides good hemostasis and visualization without chemical 
coagulation, and there is no systemic involvement.42 In 1982, Ranly, et a1.12 
stated the vital pulpotomy is accomplished by selection of a agent which 
preserves pulp vitality or promotes repair in contrast to mortal pulpotomy 
medicaments that deliberately necrotize tissue. The rationale for the 
electrosurgical pulpotomy is that the affected tissue of the coronal pulp is 
removed during pulpal amputation, and a layer of coagulation necrosis is caused 
by the electrosurgical application. This provides a barrier between healthy 
radicular tissue and any base material placed in the pulp chamber.12 
Sheller and Morton/0 in 1987, performed pulpotomies on 11 caries-free 
human primary teeth using the electrosurgical pulpotomy technique. The teeth 
selected for treatment were indicated for extraction due to anterior crowding. 
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The criteria used to define success was histological evidence of viable pulp tissue 
in the apical third of the root with no inflammation and no clinical symptoms, 
radiographic changes, periapical involvement, or internal resorption. The 
clinical and radiographic successes 100 days postoperatively were obtained with 
10 teeth, while only seven teeth showed histological success. The histologic 
results showed acute and chronic inflammation limited to the coronal third of the 
pulp with reparative dentin being located along the canal walls, and vital pulp 
tissue found in the apical third. The results from this study show that the 
electrosurgical technique produces favorable short-term results and can be used 
for the vital pulpotomy in the primary dentition. 
Ruemping, Morton, and Anderson 42 evaluated the histologic pulp 
response from the electrosurgical pulpotomy in three Macaca nemestrina 
monkeys and compared the results to the historic formocresol pulpotomy. 
Specimens were evaluated at one hour, one week, and two months 
postoperatively. Two months postoperatively the electrosurgical pulpotomy 
.revealed a minimal acute and chronic inflammatory response with a 
reorganization of fibroblasts apical to the inflammation and the formation of 
secondary dentin along the canal walls with vital tissue found in the apical third. 
The evidence of reparative dentin formation suggests an effort by a healthy pulp 
to heal the area of insult. This is comparable to the histologic results seen with 
the formocresol pulpotomy and suggests that electrosurgery is a viable 
pulpotomy procedure without the dissemination and toxic ramifications of 
formocresol. 
In contrast, Shulman, et al.,43 histologically compared the effect on the 
pulp tissue of electrosurgery and formocresol. Eighty teeth in four Macaca 
fascicularis monkeys with complete caries-free primary dentition were used and 
were observed at three, 14, 41, and 65 days postoperatively. It was found that 
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the electrosurgical technique produced pathologic root resorption and 
periapical/ furcal pathology. Shulman, et al. used electrosurgery to remove the 
coronal pulp tissue and to treat the pulpal stumps. Ruemping, et al.42 used 
mechanical pulp amputation, and then the remaining pulpal stumps were 
treated with electrosurgery. Problems with excessive production of heat and 
electricity may have been responsible for Shulman's poor results. 
Shaw, et al.44 performed electrosurgical pulpotomies in Macaca nemestrina 
monkeys and evaluated the histologic effects up to six months. This study 
differs from Ruemping, et al.42 in that only primary caries-free teeth were used 
and were evaluated over a longer period of time. These results were compared 
with the histologic tissue response produced by the conventional formocresol 
pulpotomy. The specimens were evaluated at postoperative intervals of one 
hour, three months, four months, five months, and six months. Each specimen 
was evaluated for the presence of inflammation, fibrosis, dentin formation, 
necrosis, periapical or furcation involvement, and internal/ external root 
resorption. The histologic success rate for the electrosurgical and formocresol 
pulpotomy was 84 percent and 80 percent, respectively. The histologic picture, 
for both treatments, is described as an acute and chronic inflammation limited to 
the coronal third of the pulp with the formation of reparative dentin and vitality 
of tissue in the apical third.44 
Mack and Dean,45 in 1993, conducted a clinical and radiographic 
retrospective study of the electrosurgical pulpotomy technique used on human 
primary molars in a private practice setting. The study reviewed a total of 164 
pulpotomies that were treated with the Hyfrecator 705A set at 12 watts. The 
clinical and radiographic success rate was 99.5 percent. These findings were 
compared statistically with a retrospective formocresol study performed by 
Hicks, et al.46 who showed the success rate of formocresol to be 93.9 percent. 
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This is a statistically significant difference, and the authors concluded that the 
electrosurgical pulpotomy is a viable technique. 
In 1996, Fishman, et a1.47 evaluated the clinical and radiographic success of 
ZOE and CaOH, as pulp dressings, after the electrofulguration pulpotomy 
technique. The teeth were evaluated after one, three, and six months. After six 
months, the clinical success ranged from 77 to 81 percent, and the radiographic 
success was 55 to 57 percent for both groups. The results did not compare 
favorably with other studies. However, the authors did note upon review of 
pretreatment radiographs that signs of pulpal changes were evident. Perhaps 
the selection criteria were not properly defined. It was concluded that it was 
premature to recommend electrosurgical pulpotomies until further studies could 
be conducted. 
Although several studies have investigated the electrosurgical pulpotomy 
technique, no well-controlled, long-term, human, prospective studies have been 
performed. Therefore, the purpose of this study is to prospectively compare the 
<;:linical and radiographic results of the electrosurgical and formocresol 
pulpotomy technique used on human primary molar teeth requiring pulp 
therapy secondary to carious involvement. The hypothesis of this study is that 
clinical and radiographic success rates for the electrosurgical pulpotomy 
technique in human primary molars are comparable to the clinical and 
radiographic success rates for the formocresol pulpotomy technique. By the use 
of a nonpharmacologic technique, such as electrosurgery, concerns regarding the 
toxicity of chemotherapeutic agents used in the pulpotomy procedure can be 
eliminated. 
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METHODS AND MATERIALS 
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This research is specifically designed to compare the clinical and 
radiographic results of the electrosurgical (ES) and formocresol (FC) pulpotomy 
techniques used on human primary molar teeth requiring pulp therapy 
secondary to carious involvement. Patients were recruited from the pediatric 
patient population served by the dental clinic at James Whitcomb Riley Hospital 
for Children and the Indiana University School of Dentistry. Both clinics are on 
the medical center campus of Indiana University located in Indianapolis and are 
part of the section of Pediatric Dentistry. Teeth were selected based upon the 
following criteria: 
• Symptomless, carious or near-carious exposure of the vital pulp. 
" No clinical or radiographical evidence of pulpal degeneration. 
• Possibility of proper restoration of primary molars. 
In addition to the patients meeting the criteria for need of a pulpotomy 
in a primary molar, additional acceptance criteria were that the study 
participants or their legal guardians: 
• be willing to read and sign an informational letter of consent 
(Appendix 1); 
• provide data regarding their medical history; 
• have nothing in their medical history which contraindicates a 
pulpotomy; 
• be willing to submit to periodic clinical and radiographic examination 
of the pulpotomized tooth (Appendix 2). 
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All appointments and procedures were performed at the two dental clinic 
sites at Indiana University. All pulpotomy procedures were performed by the 
principal investigators and co-investigator, or a clinician who was under 
supervision by the investigator of this project, to ensure consistency in the two 
techniques. Human primary molar teeth requiring a pulpotomy procedure 
secondary to exposure of the coronal tissue were randomly assigned by the flip 
of a coin to one of the two groups: formocresol (FC group) or electrosurgical (ES 
group). A subject with more than one tooth requiring a pulpotomy had only one 
tooth used in the study. Any other teeth from that participant requiring a 
pulpotomy were not included in the study. Following profound local anesthesia, 
quadrant rubber dam isolation, and occlusal reduction with a high-speed bur, 
the caries were removed with a large slow-speed round bur. When pulpal 
exposure occurred, the roof of the coronal pulp chamber was removed with a 
high-speed bur. Following this, the coronal pulp was amputated with hand 
instruments or with the previously mentioned large slow-speed round bur. 
In the ES group, a series of large, sterile cotton pellets were placed into the 
chamber with pressure to obtain temporary hemostasis. The cotton pellets were 
then removed and the Hyfrecator 705A electrofulguration dental electrode 
(Birtcher Medical Systems, Irvine, Calif. 92718) was immediately placed slightly 
above the tissue (i.e., 1 to 2 nun). The Hyfrecator was set at 40-percent power 
(e.g., 12 watts) using the "high" port only. The electrical arc was allowed to 
bridge the gap to the first pulpal stump for 1 second followed by a cool-down 
period of 5 seconds. Heat and electrical transfer was minimized by keeping the 
electrode as far away from the pulpal stumps and tooth structure as would still 
allow electrical arcing to occur. This procedure was repeated up to a maximum 
of three times at each pulpal orifice. Single current applications of 1 second each 
were performed to each orifice in a rotational sequence to avoid heat build-up in 
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any one area of the tooth. After each current application, a new large sterile 
pellet was placed with pressure on the next pulpal orifice to be electrosurgically 
treated to absorb any blood or tissue fluids before the next current application 
(e.g., pellet-electrode-pellet-electrode, etc.) When properly completed, the pulpal 
stumps appeared dry and completely blackened. 
For the FC group, gross hemorrhage control was obtained using dry 
sterile cotton pellets. Then, a sterile cotton pellet moistened with Buckley's 
formocresol (Sultan Chemists, Inc., Englewood, N.J.) was placed against the 
pulpal stumps for 5 minutes. If hemorrhage was not controlled, the pulpal 
stumps were checked and the pulp chamber cleansed and rinsed, then there was 
a second application of formocresol. If hemorrhage persisted, a pulpectomy was 
completed and the tooth eliminated from the study. When properly completed, 
the pulpal stumps were moist but free of hemorrhaging. 
For both groups, a reinforced ZOE dressing was placed directly on the 
radicular pulpal stumps and in the coronal pulp space. The interproximal 
~urfaces were then prepared, and the line angles were beveled and rounded with 
a high-speed bur. All teeth were then restored with stainless steel crowns. 
Either a recent preoperative or an immediate postoperative periapical 
radiographic film was obtained for each of the pulpotomized teeth. These 
patients were then placed on a six-month recall program. Each tooth was 
evaluated for clinical success by the investigators at the recall appointment. 
Clinical success was defined by the absence of pain, abscess, fistula, or excessive 
mobility. 
The radiographs of the teeth in this study were evaluated by three 
different examiners with no knowledge as to which group the particular tooth 
was assigned. The examiners selected were full-time pediatric dentistry faculty 
members at Indiana University. Each pulpotomy was judged a radiographic 
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success or failure by using criteria such as the presence of a normal periodontal 
ligament space, absence of pathologic root resorption or canal calification, and no 
periradicular radiolucency. The examiners had the option of rating the 
pulpotomy a success even though a radiographic change was associated with the 
tooth, if it were deemed by the examiners that the change was not associated 
with the pulpotomy itself (i.e., resorption secondary to an ectopic eruption) or 
that the change did not adversely affect the tooth's prognosis for normal 
retention. 
In this study failure rates were determined over the minimum six-month 
follow-up period for each technique based on the clinical and radiographic exam. 
The rates (clinical and radiographic) were compared between the two techniques 
using a Fisher's Exact test. 
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RESULTS 
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A total of 50 pulpotomies were performed. There were 25 pulpotomies in 
each group (i.e., 25 in the ES group and 25 in the FC group.) In the 
electrosurgical group, the youngest patient at the time of treatment was two 
years, two months and the oldest was eight years, one month, with a mean 
treatment age of five years, three months. The postoperative observation time 
ranged from six months to 31 months, with a mean postoperative observation 
time of 10 months (Table I). Of the 25 teeth evaluated in the ES group, 17 were 
normal at the last observation visit; one had undergone normal exfoliation; three 
had a radiographic change associated with the pulpotomized tooth (either pre-
or post-treatment), but they were not considered failures; and four were 
c?nsidered failures. Four failures out of 25 pulpotomized teeth represent a 
radiographic success rate of 84 percent (Table II). Pre- and postoperative 
radiographs of a "normal" case at the last visit are shown in Figures 1a, 1b, and 
lc. The cases classified as having changes are shown in Figures 2a, 2b, and 2c. 
Radiographs of the failed cases are shown in Figures 3a, 3b, and 3c. 
In the FC group, the youngest patient at the time of treatment was two 
years, eight month,s and the oldest was 10 years, six months, with a mean 
treatment age of 5 years, eight months. The postoperative observation time 
ranged from five to 25 months with a mean postoperative observation time of 11 
months (fable III). The minimum postoperative observation period was six 
months, but a failure occurred at five months. Of the 25 teeth studied in the FC 
group, 20 were normal at the last observation visit; two had undergone normal 
exfoliation, and one had a radiographic change associated with the 
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pulpotomized tooth (either pre- or post-treahnent); however, they were not 
considered failures. Two were considered failures. Two radiographic failures 
out of 25 teeth represent a radiographic success rate of 92 percent (Table IV). 
Pre- and postoperative radiographs of a "normal" case at the last visit are shown 
in Figures 4a and 4b. The case classified as having a radiographic change is 
shown in Figure 5. Radiographs of a failed case are shown in Figures 6a and 6b. 
In this study, the agreement between examiners was measured using 
Kappa statistics. Kappa statistics were computed for each pair of examiners and 
the overall kappa was computed at 0.603, which is interpreted as a substantial 
agreement between the examiners (Table VII). The ES and FC groups were 
compared for differences in the percentage of successes using the Fisher's Exact 
test. The electrosurgical pulpotomy success rate was 84 percent, and the 
formocresol pulpotomy success rate was 92 percent. There was not a statistically 
significant difference at the p < 0.05 level. Approximate 95 percent confidence 
intervals were computed for the percentage of successes in the two groups and 
for the difference in percentage of successes between the groups (Table VIII). 
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FIGURES AND TABLES 
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FIGURE la. Pre- and postoperative radiographs of an 
electrosurgically pulpotomized tooth (#T) that 
was normal at last observation. The pulpotomy 
was performed at age 8 years, 4 months and the 
postoperative radiograph was taken at age 
10 years, 3 months. 
28 . 
FIGURE lb. Pre- and postoperative radiographs of an 
electrosurgically pulpotornized tooth ( #K) that 
was normal at last observation. The pulpotomy 
was performed at age 4 years, 6 months and the 
postoperative radiograph was taken at age 
6 years. 
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FIGURE 1c. Pre- and postoperative radiographs of an 
electrosurgically pulpotomized tooth (#L) that 
was normal at last observation. The pulpotomy 
was performed at age 3 years, 1 month and the 
postoperative radiograph was taken at age 
3 years, 11 months. 
30 
FIGURE 2a. Tooth (#J) has distal root resorption due to 
ectopic eruption of the maxillary first 
permanent molar. 
31 
FIGURE 2b. Tooth (#S) had exudate present around the 
gingival margin of the stainless steel crown. 
32 
FIGURE 2c. Tooth (#L) had a poorly adapted crown. 
33 
FIGURE 3a. Tooth (#S) has distal root pathology. 
34 
FIGURE 3b. Tooth (#K) has undergone internal resorption. 
35 
FIGURE 3c. Tooth (#K) has undergone internal resorption. 
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FIGURE 4a. Pre- and postoperative radiographs of a 
formocresol pulpotornized tooth (#S) that 
was considered normal at last observation. 
The pulpotomy was performed at age 4 years, 
5 months and postoperative radiographs 
were taken at age 4 years, 11 months. 
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FIGURE 4b. Pre- and postoperative radiographs of a 
formocresol-pulpotomized tooth (#B) that 
was considered normal at last observation. 
The pulpotomy was performed at age 8 years, 
3 months and postoperative radiographs 
were taken at age 9 years, 4 months. 
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FIGURE 5. Tooth (#S) had exudate present around the 
stainless steel crown. 
39 
FIGURE 6a. Tooth (#T) is undergoing mesial root 
resorption. 
40 
FIGURE 6b. Tooth (#S) has furcal pathology. 
41 
TABLE I 
Electrosurgical group 
Age at time of treatment and post-op observation time 
Youngest at time of treatment 
Oldest at time of treatment 
Mean age at time of treatment 
Age range at time of treatment 
Mean post-op observation time 
Range of post-op observation time 
26 months 
97months 
63.6 months 
29-97 months 
10.9 months 
6-31 months 
42 
TABLE II 
Electrosurgical group 
Clinical and radiographic result categories 
Normal up to exfoliation 1 
Normal at last observation 
Radiographic changed noted 
Failure 
Total teeth evaluated 
17 
3 
4 
25 
Success rate = 84% 
Failure rate= 16% 
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TABLE III 
Fonnocresol group 
Age at time of treatment and post-op observation time 
Youngest at time of treatment 
Oldest at time of treatment 
Mean age at time of treatment 
Age range at time of treatment 
Mean post-op observation time 
Range of post-op observation time 
32months 
126months 
68.2months 
32-126 months 
11.5 months 
5-25 months 
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TABLE IV 
Fonnocresol group 
Clinical and radiographic result categories 
Normal up to exfoliation 2 
Normal at last observation 
Radiographic change noted 
Failure 
Total teeth evaluated 
20 
1 
2 
25 
Success rate= 92.0% 
Failure rate= 8.0% 
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TABLEV 
Electrosurgical data 
Subiect Age @ treatment Post-op time Result 
1. 100 months 23months success 
2. 50 months 20months success 
3. 60 months 31 months success* 
4. 87month 10 months fail** 
5. 66 months 6 months fail 
6. 88 months 6 months fail 
7. 82months 11 months fail 
8. 93 months 6 months success* 
9. 80 months 6months success 
10. 100 months 7months success 
11. 31 months 6 months success 
12. 37months 10 months success 
13. 42months 6 months success 
14. 54 months 18 months success 
15. 24months 6 months success 
16. 54 months 6 months success 
17. 80 months 6 months success 
18. 78months 6 months success 
19. 57 months 6 months success 
20. 84months 6 months success 
21. 52 months 7months success 
*Classified as having a radiographic change 
**Classified as a clinical failure 
(continued) 
Subject 
22. 
23. 
24. 
25. 
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TABLE V (continued) 
Electrosurgical data 
Age @ treatment 
90 months 
66months 
81 months 
69 months 
Post-op time 
30 months 
6 months 
24months 
6 months 
*Classified as having a radiographic change 
**Classified as a clinical failure 
Result 
success 
success 
success* 
success 
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TABLE VI 
Formocresol data 
Subject Age @ treatment Post-op time Result 
1. 64months 25 months success 
2. 68 months 24months failure 
3. 99 months 13 months success 
4. 66 months 12 months success* 
5. 81 months 5months failure 
6. 66months 24months success 
7. 126 months 12 months success 
8. 52 months 6 months success 
9. 36 months 6 months success 
10. 50 months 6months success 
11. 32months 6 months success 
12. 64months 9 months success 
13. 88 months 6 months success 
14. 52 months 6 months success 
15. 51 months 10 months success 
16. 53 months 6 months success 
17. 44months 12months success 
18. 67months 6 months success 
19. 47months 6 months success 
20. 67months 6 months success 
21. 67months 19 months success 
22. 51 months 6 months success 
*Classified as having a radiographic change 
(continued) 
Subject 
23. 
24. 
25. 
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TABLE VI (continued) 
Formocresol data 
Age @ treatment 
58 months 
41 months 
75months 
Post-op time 
8months 
24months 
24months 
*Classified as having a radiographic change 
Result 
success 
success 
success 
Poor agreement 
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TABLE VII 
Kappa interpretation 
Slight agreement 
Fair agreement 
Moderate agreement 
Substantial agreement 
Almost perfect agreement 
below 0.0 
0.00-0.20 
0.21-0.40 
0.41-0.60 
0.61-0.80 
0.81-1.00 
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TABLE VIII 
Interrater reliability scores 
Dr. 1 & Dr. 2 0.548 
Dr. 1 & Dr. 3 0.565 
Dr. 2 & Dr. 3 0.737 
Overall 0.603 
Group # Successes 
Fornrrocresol 23 
Electrosurg. 21 
Difference 
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TABLE IX 
Statistical analysis 
Total# % Success Confidence Interval 
25 
25 
92% (74%, 99%) 
84% (64%, 95%) 
8% (0%, 30%) 
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DISCUSSION 
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The use of formocresol in the primary dentition as a pulpotomy agent has 
been well-documented in the literature since its introduction into dentistry in 
1904. Over the years studies have shown formocresol to yield reasonable success 
rates when used as a pulpotomy medicament.13'46 Formocresol is the most 
accepted and widely used agent today, and any study investigating a new 
pulpotomy technique or agent should use formocresol as the control. Despite its 
favorable outcomes, formocresol has been shown to be a carcinogenic, 
mutagenic, allergenic, and potentially toxic agent that is systemically distributed 
in animal studies. Concerns over these findings have led investigators to search 
for a nonpharmacologic agent, and electrosurgery has been investigated as a 
result. 
The. original protocol of this study was revised after a two-year delay in 
completing the study. The modifications included performing 50 pulpotomies 
for evaluation instead of 100, having three examiners instead of two due to time 
constraints (eliminating the need for a conference between the examiners 
resolving their differences), and the use of kappa statistics. Kappa is a popular 
measure of association and is usually used to examine interobserver agreement 
on diagnostic tests, such as radiographs. In this study, with multiple examiners 
being used, kappa was used to do an intraclass correlation. The examiners were 
paired and a score was determined on their combined reliabil ty. The scores fell 
in the range of moderate to substantial agreement, and this level is considered 
good. The average of the overall score shows that the examiners were in 
substantial agreement. And finally, the co-investigator, who was a postgraduate 
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pediatric dental resident using this project to fulfill his requirements for the 
Master of Science in Dentistry degree, was added to the study after being taught 
the electrosurgical technique by the principal investigator. 
In this study, the examiners had the choice of rating each tooth a success, a 
success with a radiographic change, or a failure based on the selected criteria. Of 
the three successes having radiographic changes in the electrosurgical group, one 
tooth had a poor-fitting stainless steel crown; the other tooth had exudate 
expressed from the sulcus believed to be due to gingival irritation, probably 
caused by the stainless steel crown, and the third exhibited radiographic 
evidence of distal root resorption secondary to ectopic eruption of the maxillary 
first permanent molar as shown in Figures 2a, 2b, and 2c. All three abnormalities 
were asymptomatic at the last evaluation appointment. Appointments for 
replacement of the ill-fitting crowns were scheduled. These cases were difficult 
to categorize by the three examiners. The examiners said that the radiographic 
changes. were not directly related to the pulpotomies themselves, so that they 
were judged successful, even though they could not be included as "normal." 
Radiographs of the failed cases are shown in Figures 3a, 3b, 3c, and 3d. One case 
(Figure 3a) exhibited clinical signs and symptoms of morbidity and radiographic 
pathology and was extracted 10 months after performing electrosurgical pulp 
therapy; a space maintainer was placed to prevent space loss. The other cases 
exhibited radiographic evidence of distal root resorption (Figure 3b) and internal 
root resorption (Figures 3c, 3d) without clinical signs or symptoms of morbidity. 
In the FC group, the tooth classified as a success having a radiographic 
change had exudate present around the gingival margin of the stainless steel 
crown. The examiners felt that the radiographic change was not directly related 
to the pulpotomy itself, so that it was judged a success, even though it could not 
be included as "normal." The tooth was asymptomatic with no signs of 
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radiographic pathology. Radiographs of the two failed cases are shown in Figure 
5. The first case exhibited radiographic evidence of internal root resorption 
without clinical signs or symptoms of morbidity and the second case exhibited 
radiographic evidence of furcal pathology without clinical signs or symptoms of 
morbidity. 
The electrosurgical pulpotomy has gained popularity due to its 
nonpharmacologic nature, ease in use, and reported favorable results. The 
results of our study are comparable to those reported in the literature concerning 
electrosurgical and formocresol pulpotomies.10,13,16A5,46 Ruemping42 and Shaw44 
have reported histological success when using electrosurgery on caries-free 
primate teeth. Shulman 43 evaluated the pulp response of caries-free primate 
teeth histologically after being treated by electrosurgery. The study reported a 
histologic success of 56 percent. The poor results were possibly caused by the 
complete removal of the coronal pulp tissue with the electrosurgical unit, instead 
of the s_tandard electrosurgical technique, which is to remove the coronal tissue 
mechanicaily and then treat the pulpal stumps with electrosurgery. Shulman's 
technique possibly caused excessive heat accumulation within the pulp and 
caused more necrosis. In comparison, Rolling and Hansen24 evaluated the 
histological response of the pulp when treated with formocresol. The teeth were 
treated three to 24 months prior and were determined to be clinically and 
radiographically successful. The purpose of their study was to establish a 
relationship between the pulpal condition in short and long-term pulpotomized 
teeth. The findings led the authors to presume that complete repair of the pulp 
tissue could occur, but it is not a characteristic reaction after formocresol 
treatment. Therefore, they concluded that the formocresol pulpotomy is only a 
means to keep primary teeth with pulp exposures functioning for a limited 
period of time. 
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10 45 . 47 Sheller and Morton, Mack and Dean, and Ftshman conducted human 
studies using electrosurgical pulpotomies. Sheller and Morton10 reported a 
clinical and radiographic success of 91 percent when using caries-free canines in 
humans, but a histologic success of only 64 percent. The poor histologic results 
may be directly related to the use of gutta percha as the base material instead of 
the standard base of ZOE, which was used by Ruemping42 and Shaw.44 In a 
retrospective study by Mack and Dean,45 they reviewed 164 electrosurgically 
pulpotomized teeth that had been treated within the last 10 years and reported a 
clinical and radiographic success rate of 99.5 percent. Even though this was a 
retrospective study and variations in the pulpotomy technique over the years 
probably occurred, the results are noteworthy and comparable to the 
retrospective study done by Hicks.46 The study by Mack and Dean included 164 
formocresol pulpotomies that were evaluated and reported to have a clinical and 
radiographic success rate of 93.9 percent. 
In a' recent prospective human study on the electrosurgical pulpotomy, 
Fishman et al.47 compared the clinical and radiographic success rates between 
two different pulpotomy covering medicaments, ZOE and CaOH. They 
demonstrated clinical success rates of 77 and 81 percent, and radiographic 
success rates of 55 and 57 percent for the ZOE and CaOH, respectively. 
Compared with the Mack and Dean 45 retrospective study and our current study, 
their success rate is low. Several comments may help to explain the discrepancy. 
First, the authors were attempting to compare the success rates of ZOE or CaOH 
as pulpotomy medicaments, not the overall success of the electrosurgical 
technique as compared with a gold standard such as formocresol. Second, the 
authors noted that upon review of their pretreatment radiographs, pathology 
was present on some teeth, which indicated these teeth possibly required more 
extensive pulp therapy besides a pulpotomy. Third, the authors did not include 
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a rating category "success with a radiographic change" in their study. This is 
important, because factors other than the pulpotomy technique can cause 
pathology, i.e., poor fitting crowns or ectopic erupting molars. Finally, it is 
possible, although unlikely, that their technique was flawed. While the authors 
note direct communication with Dr. Ronald Mack, a noted authority in the 
electrosurgical technique, they did not receive any clinical training from him. 
The authors conclude their paper by stating that given the results of their study, 
it would be premature to recommend the use of the electrosurgical pulpotomy 
technique. This conclusion may be inappropriate, because their study was 
specifically designed to compare two different pulpotomy-covering 
medicaments after electrosurgical pulpotomies, not the success rate of the 
electrosurgical pulpotomy versus the formocresol pulpotomy. The results of our 
study indicate that the electrosurgical pulpotomy seems to be comparable to the 
formocresol pulpotomy for human primary molars for a postoperative period of 
a least six months. 
As with most studies, this study has its limitations. For instance, some of 
the patients recruited for this study were treated in the operating room due to 
poor behavior in the clinical setting. This provided difficulty in obtaining ideal 
postoperative radiographs for evaluation. In addition, minor variations in 
performing the pulpotomy technique could have occurred between the two 
investigators, even though strict adherence to detail was given. However, 
despite the differences in experience levels between the two investigators, the 
failures were divided equally between the investigators. 
Although the electrosurgical pulpotomy is a nonpharmacologic technique 
that produces favorable results, it is still a preservative technique. Future studies 
should investigate agents that leave the radicular pulp healthy and completely 
enclosed within an odontoblast-lined dentin chamber. One promising method 
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currently under investigation is the use of bone morphogenetic protein (BMP). 
Recent experiments have, in fact, demonstrated that BMP from both bone and 
dentin will promote dentinogenesis.48,49 
59 
SUMMARY AND CONCLUSIONS 
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This study compared electrosurgical pulpotomies and formocresol 
pulpotomies in human primary molars requiring pulp therapy after carious 
involvement. The purpose was to determine how the electrosurgical pulpotomy 
compares to the formocresol pulpotomy for retaining the teeth described above. 
A total of 50 pulpotomies were performed on 50 pediatric patients 
requiring pulp therapy secondary to carious involvement. The teeth were 
assigned to one of two groups: 1) electrosurgery (ES) or 2) formocresol (FC). 
Before treatment the patients' medical histories were reviewed and the consent 
forms signed by the parents or guardians and patients. A preoperative clinical 
exam and radiograph were made on each tooth. After at least five months, the 
teeth were ~valuated by the investigators for clinical success and by three 
additional examiners for radiographic success. The examiners classified each 
tooth as a success, a success having a radiographic change, or a failure. The 
radiographic change was defined as a noteworthy radiographic finding that was 
not believed to be directly related to the pulpotomy, and that did not affect the 
success of the pulpotomy. In the ES group, 25 pulpotomies were performed in 
pediatric patients between the ages of 26 to 97 months. The postoperative 
observation time range was between six to 31 months. In the FC group, 25 
pulpotomies were performed on children between the ages 32 to 126 months. 
The postoperative observation time range was between five to 25 months. The 
clinical success rate for electrosurgery and forrnocresol was 96 percent and 100 
percent and the radiographic success rate was 84 percent and 92 percent, 
respectively. The ES and FC groups were compared for differences in the 
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percentage of successes using a Fisher's Exact test. There were no statistical 
differences between the two groups at the p < O.OSlevel. Kappa statistics was 
used to measure the agreement among the examiners. 
In conclusion, the hypothesis that the success rate of the electrosurgical 
pulpotomy is comparable to the formocresol pulpotomy is supported by this 
research. 
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APPENDIX1 
INFORMED CONSENT STATEMENT 
for 
Comparison of Formocresol vs. Electrosurgical Pulpotomy Procedures 
The Department of Pediatric Dentistry at the Indiana University School of 
Dentistry is inviting you and your child to participate in a research study. The 
purpose of this study is to determine if there is a safe and effective alternative 
technique for performing pulpotomy procedures in primary molars. Fifty 
children between the ages of 18 months and 10 years of age will be asked to 
participate. If you decide to participate, you must first read this letter and sign 
your name in the space provided. 
Your child's dentist or dental student has determined that your child 
needs a pulpotomy procedure performed on a primary molar t~oth. A 
pulpotomy involves removing the diseased or infected pulp tissue within a tooth 
and leaving the healthy, unaffected pulp tissue in place. This healthy tissue must 
be treated to stop any bleeding prior to placement of a restoration. In this study, 
your child will be treated with one of two pulpotomy procedures, a formocresol 
technique or an electrosurgical technique. Selection of the technique will be on a 
random basis by the principal investigator of this study, who will perform the 
procedure. 
As part of this study you and your child will be asked to return to the 
clinic at 6 month intervals following the pulpotomy. Clinical and radiographic 
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observations of the treated teeth will be made. You will be compensated $20.00 
at the completion of the 6 month follow-up visit for your participation in the 
study. 
The risks associated with both pulpotomy techniques include failure of 
the pulpotomy procedure with the need for either a pulpectomy or extraction of 
the tooth and space maintenance. The risks involved will be minimized by 
adhering to all accepted infection control and safety guidelines associated with 
performing pulpotomy procedures. When needed, the principle investigator will 
ensure the availability of follow-up care for the study participant. You and your 
child will be notified immediately if any adverse clinical and radiographic 
sequela of the study's treatment are observed: 
I have been given an opportunity to ask questions about this study; 
answers to such questions (if any) have been satisfactory. The information in the 
study will be kept confidential and will be made available only to persons 
condu~ting the study unless I specifically give my permission in writing to do 
otherwise. If the results of this study are published, I will not be identified. I 
understand that the results of the study may be submitted to Birtcher Medical 
Systems and to the Food and Drug Administration. In the unlikely event of 
physical injury resulting from my participation in this research, emergency 
medical treatment will be provided by the James Whitcomb Riley Hospital for 
Children. 
If I have questions regarding the study I can reach Dr. Brad Fulkerson at 
274-3865. If I am unable to reach Dr. Fulkerson at this number in an emergency, I 
may call 27 4-5000 and ask for the pediatric dentistry resident on call. A patient 
representative who is not associated with this research to whom I may address 
complaints about this study, as well as questions about my rights as a research 
participant, may be reached at 274-6637. In consideration of all of the above, I 
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give my consent to participate in this voluntary research study. I understand 
that I may drop out of or be withdrawn from the study without fear of changing 
the investigator's interest or the quality of medical care which I may seek or 
receive in the future from the doctors participating in the study. I acknowledge 
receipt of a copy of this informed consent statement. 
Subiect's name Date: 
J ----------------------------------- ------
Signature of Parent/Legal Guardian _____________ _ 
Signature of Child (Age 7 and above) ____________ _ 
Signature of Witness ________________________________________ _ 
Chart# 
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APPENDIX2. 
Examination Sheet 
Panelist Data Sheet 
ES vs. FC Prospective Pulpotomy Study 
Tooth# 
----- --
Tx: ES/FC Tx. Date ___ _ 
Consent signed and attached __ Med Hx: Neg/Pos 
Date Elapsed Time 
0 
6 months 
12 months 
18 months 
24months 
36 months 
48 months 
60 months 
Exfoliation 
X-ray Success Failure (describe) 
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ABSTRACT 
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COMPARISON OF ELECIROSURGICAL AND FORMOCRESOL 
PULPOTOMY PROCEDURES 
by 
Bradley T. Fulkerson 
Indiana University School of Dentistry 
Indianapolis, Indiana 
Formocresol is the most commonly used pharmacologic pulpotomy agent. 
Concerns over its safety have led investigators to search for new pulpotomy 
medicaments. This study compared the electrosurgical pulpotomy with the 
formocresol pulpotomy in teeth requiring pulp therapy after carious 
involvement. There were 25 pulpotomies performed in each group. The teeth 
were evaluated for clinical and radiographic success after at least six months. In 
the electrosurgical group, the clinical and radiographic success rates were 96 
percent and 84 percent, respectively. The age range at the time of treatment was 
26 to 97 months, with a mean treatment age of 63.6 months. The postoperative 
observation time range was six to 31 months, with the mean being 10.9 months. 
In the formocresol group, the clinical and radiographic success rates were 100 
percent and 92 percent, respectively. The age range at the time of treatment was 
32 to 126 months, with a mean treatment age of 68.2 months. The postoperative 
observation time ranged from five to 25 months, with the mean being 11.5 
months. The electrosurgical and forrnocresol groups were compared for 
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differences in the percentage of successes by using a Fisher's Exact test. There 
were no statistical differences between the two groups at the p < O.OSlevel. 
Therefore, this study failed to demonstrate a statistically significant difference in 
the success rate between the electrosurgical and formocresol pulpotomy 
techniques and supports the use of the electrosurgical pulpotomy as a viable and 
safe alternative to formocresol. 
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